Anemia in Cancer

Home
Web Site Map

Research

Anemia in Cancer Bladder Cancer BCG Failure Interferon BCG in IC BPH ED Erectile dysfunction Hot Flashes Impotence Interferon Interstitial Cystitis Prostatic Blockage Prostatitis Urge incontinence Urgency Incontinence Urinary urgency

Amgeit-PCA-UI

Closed

A multi-center clinical research trial is open to adult oncology patients suffering from chronic anemia caused by cancer, chemotherapy or radiotherapy.

Summary: This clinical research trial will evaluate the safety and efficacy of an investigational drug in the treatment of chronic anemia of cancer.

Eligible patients who choose to participate will have weekly clinic visits for 16 weeks (12 weeks of dosing and a 4-week follow-up).

In order to participate in this study, the following requirements must be met:

	Subjects must be at least 18 years old.
	Subjects must have anemia predominantly due to cancer or previous chemotherapy or radiotherapy. For purposes of this study, anemia is defined as having a hemoglobin level of < 11.0/dl.
	Subjects must have a non-myeloid malignancy -with no CNS involvement.
	Subjects must not be receiving or be planned to receive cytotoxic chemotherapy or radiotherapy -while on the study.
	Subjects may not currently be treated with, or have been treated in the last 30 days, with any other investigational device or drug.
	Subjects may not be screened for this study until at least 8 weeks have passed since their last chemotherapy dose. Other protocol inclusion / exclusion criteria must be met as determined by clinical staff during subject screening.

Contact: Lisa Blevins at (301) 441-4402

or via internet: APPLY

[Home]

Drs Werner, Murdock & Francis

Greenbelt - Bowie - Laurel Maryland

(301) 441-8900 Fax (301) 982 0453

7500 Hanover Parkway Suite 206 Greenbelt, MD 20770

Research : (301) 441-4402

e-mail: wmfuro@cs.com

contact us

Rev: 08/03